Skip to main content

Quelicin Side Effects

Generic name: succinylcholine

Medically reviewed by Last updated on Sep 14, 2023.

Note: This document contains side effect information about succinylcholine. Some dosage forms listed on this page may not apply to the brand name Quelicin.

Applies to succinylcholine: solution.

Serious side effects of Quelicin

Along with its needed effects, succinylcholine (the active ingredient contained in Quelicin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking succinylcholine:

Incidence not known

Other side effects of Quelicin

Some side effects of succinylcholine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to succinylcholine: compounding powder, injectable powder for injection, injectable solution, intravenous solution.


Very rare (less than 0.01%): Anaphylaxis[Ref]


Very common (10% or more): Muscle fasciculation, post-operative muscle pain

Common (1% to 10%): Myoglobinemia, myoglobinuria

Rare (less than 0.1%): Trismus

Frequency not reported: Rhabdomyolysis, myoglobinuria, myoglobinemia, elevated creatine phosphokinase, hypertonia, precipitation or exacerbation of myasthenia gravis[Ref]


Common (1% to 10%): Increased intraocular pressure[Ref]


Common (1% to 10%): Hyperkalemia[Ref]


Rare (0.01% to 0.1%): Bronchospasm, prolonged respiratory depression, apnea

Very rare (less than 0.01%): Increased bronchial secretions, pulmonary edema (in infants)[Ref]


Very rare (less than 0.01%): Malignant hyperthermia, porphyria[Ref]


Frequency not reported: Renal failure[Ref]


Common (1% to 10%): Bradycardia, tachycardia, flushing, hypertension, hypotension

Rare (less than 0.1%): Arrhythmias (including ventricular arrhythmia), cardiac arrest, hyperkalemia-related cardiac arrest (following administration to patients with congenital cerebral palsy, tetanus, Duchenne muscular dystrophy, and closed head injury)

Frequency not reported: Circulatory collapse, shock[Ref]


Common (1% to 10%): Rash[Ref]


Very common (10% or more): Increased intragastric pressure, excessive salivation

Frequency not reported: Increased bowel movements, increased gastric secretions[Ref]


1. Product Information. Anectine (succinylcholine). Glaxo Wellcome. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

4. Product Information. Quelicin Chloride (succinylcholine). Abbott Pharmaceutical. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.